Safety and tolerability of Neoral in transplant recipients. - Suppr | 超能文献

Safety and tolerability of Neoral in transplant recipients.

作者信息

Feutren G, Wong R, Jin J, Niese D, Mellein B

机构信息

Sandoz Research Institute, East Hanover, NJ 07936, USA.

出版信息

Transplant Proc. 1996 Aug;28(4):2177-82.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Safety and tolerability of Neoral in transplant recipients.

Transplant Proc. 1996 Aug;28(4):2177-82.

2

Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.

Transplant Proc. 1996 Aug;28(4):2183-6.

3

Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.

Transplant Proc. 1995 Aug;27(4):2488-90.

4

A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.

Transplant Proc. 1996 Dec;28(6):3365-7.

5

Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.

Transplant Proc. 1996 Dec;28(6):3348-50.

6

Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.

Transplant Proc. 1996 Dec;28(6):3379.

7

Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353.

Transplant Proc. 1996 Aug;28(4):2196-8.

8

Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.

Transplant Proc. 1996 Jun;28(3):1330-2.

9

Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.

Transplant Proc. 1996 Aug;28(4):2204-6.

10

Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.

Transplant Proc. 1996 Aug;28(4):2187-8.

引用本文的文献

1

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.

2

Switching between cyclosporin formulations. What are the risks?

Drug Saf. 1997 Jun;16(6):366-73. doi: 10.2165/00002018-199716060-00003.